Softwr

Healthcare · head to head

PathAI vs TheraNest

PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite
TheraNest logo

TheraNest

Healthcare

Mental health EHR and practice management priced per therapist

From
$29/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.; TheraNest the Essentials plan includes no insurance claims at all, so any practice that bills a payer is effectively on the 59 USD tier or above and the advertised 29 USD entry price does not apply to it.
  • They diverge on capability: PathAI covers AISight image management, TheraNest covers Progress notes and treatment plans.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which PathAI and TheraNest actually diverge.

Attributes where PathAI and TheraNest differ
AttributePathAITheraNest
Starting priceOn request$29/month
Pricing modelquotePer user per month
PlatformsWebWeb, iOS, Android

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

Only in TheraNest

  • Progress notes and treatment plans
  • Insurance claims
  • Client portal
  • Telehealth
  • Group and family sessions
  • Payroll and staff reporting

What people use each for

The jobs each tool is most often brought in to do.

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot TheraNest
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot TheraNest
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot TheraNest
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot TheraNest

TheraNest

  • A solo therapist who needs a HIPAA aligned note and scheduling system and does not bill insurance, where the 29 USD entry tier is genuinely sufficientnot PathAI
  • A group practice of six to twenty clinicians that wants per clinician productivity and payroll reporting without buying a separate practice management layernot PathAI
  • A practice moving off paper or a general purpose calendar that needs a client portal for intake forms and consent signaturesnot PathAI
  • A behavioural health organisation that bills a steady volume of insurance claims each month and can size the Advanced allowance against its actual claim countnot PathAI

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

TheraNest

  • The Essentials plan includes no insurance claims at all, so any practice that bills a payer is effectively on the 59 USD tier or above and the advertised 29 USD entry price does not apply to it.
  • Telehealth is only in the Premier plan, so a practice that wants video sessions pays 89 USD per therapist per month even if it needs nothing else from that tier.
  • An annual AMA CPT licence fee is billed separately each December on top of subscription cost, which surprises practices that budgeted only the monthly figure.
  • Additional administrative users are chargeable, so a practice with front desk and billing staff who never see clients still pays 19 to 29 USD per head for people who generate no revenue.
  • The product sits inside a consolidated portfolio that has already renamed the parent company from Therapy Brands to Ensora Health, and product investment in a portfolio is directed by the owner rather than by this product line, so roadmap commitments are worth less than they would be from a single product vendor.

Pricing, plan by plan

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

TheraNest

$29/month
  • Essentials$29/month
    • Per therapist
    • Scheduling and client portal
    • HIPAA aligned notes and documentation
  • Advanced$59/month
    • Per therapist
    • 30 insurance claims per month included
    • Custom forms
  • Premier$89/month
    • Per therapist
    • Unlimited insurance claims
    • Billing automation

Which should you pick?

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Choose TheraNest if

  • You need progress notes and treatment plans.
  • You work on Web, iOS, Android.
  • You also want insurance claims.
TheraNest review

Questions people ask

Is PathAI or TheraNest better?
Neither clearly leads. PathAI starts at On request and TheraNest at $29/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, PathAI or TheraNest?
PathAI starts at On request and TheraNest at $29/month.
Does PathAI or TheraNest run on more platforms?
PathAI runs on Web. TheraNest runs on Web, iOS, Android.
What is PathAI best used for?
PathAI is most often used for an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version, a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location, a pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readers, a laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewer. Of those, an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version and a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location are not what TheraNest is typically brought in for.
What can PathAI do that TheraNest cannot?
PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management. TheraNest covers Progress notes and treatment plans, Insurance claims, Client portal, Telehealth.

Answered from the vendors’ own pages

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

TheraNest: Is TheraNest still sold under that name?

Yes. The company rebranded from Therapy Brands to Ensora Health and the product is now marketed as TheraNest by Ensora Health, but you still buy TheraNest.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

TheraNest: Can I bill insurance on the cheapest plan?

No. Essentials includes no claims. Advanced includes 30 claims a month and Premier is unlimited.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

TheraNest: Are there hidden costs?

Two. Additional admin users are charged per head, and an AMA CPT licence fee is billed annually in December per therapist.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

TheraNest: Does it support group practices?

Yes, with per clinician reporting and payroll figures, though every clinician and every admin is a paid seat.

Share

Related pages

More on PathAI

More on TheraNest

Keep looking

Other head to heads